PTK2 and breast cancer: ITGBL1 was reported to promote breast cancer bone metastasis through TGF-β signaling [95] (being FAK a known mediator of TGF-β signaling [96]) and CRC migration and invasion, possibly also through the FAK signaling pathway [97].